chr16-84172347-T-C

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_178452.6(DNAAF1):ā€‹c.1616T>Cā€‹(p.Leu539Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00078 in 1,614,210 control chromosomes in the GnomAD database, including 10 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā˜…ā˜…). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. L539M) has been classified as Uncertain significance.

Frequency

Genomes: š‘“ 0.0040 ( 4 hom., cov: 33)
Exomes š‘“: 0.00044 ( 6 hom. )

Consequence

DNAAF1
NM_178452.6 missense

Scores

2
16

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -0.252
Variant links:
Genes affected
DNAAF1 (HGNC:30539): (dynein axonemal assembly factor 1) The protein encoded by this gene is cilium-specific and is required for the stability of the ciliary architecture. It is involved in the regulation of microtubule-based cilia and actin-based brush border microvilli. Mutations in this gene are associated with primary ciliary dyskinesia-13. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2016]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.003911704).
BP6
Variant 16-84172347-T-C is Benign according to our data. Variant chr16-84172347-T-C is described in ClinVar as [Likely_benign]. Clinvar id is 262943.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00404 (616/152366) while in subpopulation AFR AF= 0.0141 (585/41580). AF 95% confidence interval is 0.0131. There are 4 homozygotes in gnomad4. There are 297 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 4 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
DNAAF1NM_178452.6 linkuse as main transcriptc.1616T>C p.Leu539Pro missense_variant 9/12 ENST00000378553.10

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
DNAAF1ENST00000378553.10 linkuse as main transcriptc.1616T>C p.Leu539Pro missense_variant 9/121 NM_178452.6 P1Q8NEP3-1
DNAAF1ENST00000563818.5 linkuse as main transcriptn.1293T>C non_coding_transcript_exon_variant 5/82
DNAAF1ENST00000570298.5 linkuse as main transcriptn.1770T>C non_coding_transcript_exon_variant 9/112
DNAAF1ENST00000563093.5 linkuse as main transcriptc.*171T>C 3_prime_UTR_variant, NMD_transcript_variant 10/112 Q8NEP3-3

Frequencies

GnomAD3 genomes
AF:
0.00403
AC:
613
AN:
152248
Hom.:
4
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0140
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00150
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000441
Gnomad OTH
AF:
0.00239
GnomAD3 exomes
AF:
0.00102
AC:
257
AN:
251448
Hom.:
1
AF XY:
0.000839
AC XY:
114
AN XY:
135900
show subpopulations
Gnomad AFR exome
AF:
0.0143
Gnomad AMR exome
AF:
0.000607
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000264
Gnomad OTH exome
AF:
0.000163
GnomAD4 exome
AF:
0.000440
AC:
643
AN:
1461844
Hom.:
6
Cov.:
31
AF XY:
0.000386
AC XY:
281
AN XY:
727218
show subpopulations
Gnomad4 AFR exome
AF:
0.0151
Gnomad4 AMR exome
AF:
0.000648
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000116
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000144
Gnomad4 OTH exome
AF:
0.00126
GnomAD4 genome
AF:
0.00404
AC:
616
AN:
152366
Hom.:
4
Cov.:
33
AF XY:
0.00399
AC XY:
297
AN XY:
74512
show subpopulations
Gnomad4 AFR
AF:
0.0141
Gnomad4 AMR
AF:
0.00150
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000441
Gnomad4 OTH
AF:
0.00236
Alfa
AF:
0.000722
Hom.:
3
Bravo
AF:
0.00441
ESP6500AA
AF:
0.0127
AC:
56
ESP6500EA
AF:
0.000349
AC:
3
ExAC
AF:
0.00133
AC:
161
Asia WGS
AF:
0.000577
AC:
2
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Benign, criteria provided, single submitterclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineFeb 21, 2013Leu539Pro in exon 9 of DNAAF1: This variant is not expected to have clinical sig nificance because it has been identified in 1.3% (56/4400) of African American c hromosomes from a broad population by the NHLBI Exome Sequencing Project (http:/ /evs.gs.washington.edu/EVS; dbSNP rs141149453). -
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
Primary ciliary dyskinesia Benign:2
Benign, criteria provided, single submitterclinical testingInvitaeJan 22, 2024- -
Benign, criteria provided, single submitterclinical testingAmbry GeneticsAug 03, 2015This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Primary ciliary dyskinesia 13 Benign:1
Likely benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.11
BayesDel_addAF
Benign
-0.68
T
BayesDel_noAF
Benign
-0.74
CADD
Benign
7.6
DANN
Benign
0.95
DEOGEN2
Benign
0.027
T
Eigen
Benign
-1.2
Eigen_PC
Benign
-1.4
FATHMM_MKL
Benign
0.024
N
LIST_S2
Benign
0.41
T
MetaRNN
Benign
0.0039
T
MetaSVM
Benign
-0.97
T
MutationAssessor
Benign
0.94
L
MutationTaster
Benign
1.0
N
PrimateAI
Benign
0.30
T
PROVEAN
Uncertain
-2.7
D
REVEL
Benign
0.019
Sift
Benign
0.064
T
Sift4G
Uncertain
0.019
D
Polyphen
0.022
B
Vest4
0.20
MVP
0.16
MPC
0.17
ClinPred
0.0083
T
GERP RS
-5.5
Varity_R
0.14
gMVP
0.38

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.050
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs141149453; hg19: chr16-84205953; API